Refractory primary immune thrombocytopenia with subsequent del(5q) MDS: complete remission of both after lenalidomide (Q33438158)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Refractory primary immune thrombocytopenia with subsequent del(5q) MDS: complete remission of both after lenalidomide	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

0 references

Refractory primary immune thrombocytopenia with subsequent del(5q) MDS: complete remission of both after lenalidomide (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

thrombocytopenia

1 reference

based on heuristic

inferred from title

Henrik Frederiksen

object named as

Henrik Frederiksen

2

0 references

author name string

Thomas Bech Mortensen

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Claus Werenberg Marcher

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Birgitte Preiss

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

4 January 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

BMJ case reports

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

2017

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production

1 reference

https://pubmed.ncbi.nlm.nih.gov/28052942

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

International consensus report on the investigation and management of primary immune thrombocytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/28052942

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A case of refractory thrombocytopenia with 5q deletion: myelodysplastic syndrome mimicking idiopathic thrombocytopenic purpura

1 reference

https://pubmed.ncbi.nlm.nih.gov/28052942

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS.

1 reference

https://pubmed.ncbi.nlm.nih.gov/28052942

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Myelodysplastic syndromes: Contemporary review and how we treat

1 reference

https://pubmed.ncbi.nlm.nih.gov/28052942

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autoimmune diseases and myelodysplastic syndromes

1 reference

https://pubmed.ncbi.nlm.nih.gov/28052942

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/28052942

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/BCR-2016-215888

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PMC publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33438158&oldid=1606846375"